Legend Biotech Corporation
LEGN
$19.01
-$0.33-1.71%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 68.35% | -24.24% | -483.94% | 120.97% | -588.73% |
| Total Depreciation and Amortization | 0.43% | 12.60% | -21.11% | 68.67% | -27.23% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -89.16% | 116.74% | 286.85% | -143.21% | 902.73% |
| Change in Net Operating Assets | 232.63% | 51.63% | 8.10% | -124.94% | -1,256.19% |
| Cash from Operations | 320.83% | 87.43% | -26.41% | -8.25% | -4,492.49% |
| Capital Expenditure | 45.74% | -360.74% | 15.81% | -15.16% | 39.57% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 90.41% | -160.43% | 402.63% | -125.81% | 147.84% |
| Cash from Investing | 87.92% | -164.50% | 392.16% | -126.69% | 147.31% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 52.34% | -62.55% | 16.99% | 19.59% | -0.34% |
| Issuance of Common Stock | 365.93% | -81.09% | 139.47% | -88.85% | 155.74% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 167.68% | -248.43% | 300.30% | -107.84% | 344.50% |
| Foreign Exchange rate Adjustments | -36.12% | 217.21% | 161.54% | -534.16% | 5,722.22% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 107.03% | -213.01% | 189.81% | -166.87% | 137.06% |